Processed single-cell RNA-seq count matrices (barcodes, features, matrix) for 6 samples from the tunlametinib Phase IIa trial: 3 treated patients (P01006 gradual responder, P01007 gradual responder, P01011 rapid responder) and 3 untreated PN controls. Raw FASTQs not deposited due to IRB restrictions. Source: GEO GSE317549 / ENA PRJNA1414442. Created By NADIA Bot nadia-bot
study: Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1-Associated Plexiform Neurofibromas contentType: dataset resourceStatus: pendingReview externalRepository: GEO externalAccessionID: GSE317549